Effects of Early and Late Time-restricted Eating on Overweight Adults With Metabolic Syndrome
1 other identifier
interventional
103
1 country
1
Brief Summary
Investigators aim to compare the effects of early and late time-restricted feeding on overweight adults with metabolic syndrome
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 13, 2023
CompletedFirst Posted
Study publicly available on registry
August 30, 2023
CompletedStudy Start
First participant enrolled
May 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 16, 2024
CompletedDecember 22, 2025
December 1, 2024
5 months
August 13, 2023
December 19, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Changes in body weight
Body weight is assessed at the research center with the participants without shoes and in light clothing using a digital scale (OMRON MEDICAL Beijing Co., Ltd. HNH-318) to the nearest 0.1 kg.
0-week; 6-week and 12-week
Changes in abdominal fat area
Abdominal fat area is measured using bioelectrical impedance analysis (OMRON MEDICAL Beijing Co., Ltd. DUALSCAN, HDS-2000) to the nearest 1 cm2.
0-week; 6-week and 12-week
Secondary Outcomes (7)
Changes in body composition ( body fat mass)
0-week and 12-week
Changes in body composition (body muscle mass)
0-week and 12-week
Changes in glycemic control
0-week; 6-week and 12-week (glucose and insulin)0-week and 12-week (HbA1c)
Changes in hemoglobin A1c (HbA1c)
0-week; 6-week and 12-week (glucose and insulin)0-week and 12-week (HbA1c)
Changes in total cholesterol, triglyceride (TG), high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c)
0-week; 6-week and 12-week
- +2 more secondary outcomes
Study Arms (2)
Early time-restricted eating (eTRE)
EXPERIMENTALThe eTRE group is instructed to consume all calories from 7 AM to 3 PM each day and fast from 3 PM to 7 AM
Late time-restricted eating (lTRE)
EXPERIMENTALThe lTRE group is instructed toconsume all calories from 11 AM to 7 PM each day and fast from 7 PM to 11 PM
Interventions
The eTRE group is instructed to consume all calories in early 8h eating window,
The lTRE group is instructed to consume all calories in late 8h eating window.
Eligibility Criteria
You may qualify if:
- Age from 18 to 65 years
- Body mass index (BMI): 24.0-40.0 kg/m2
- Diagnosed with metabolic syndrome (i.e., more than 3 abnormal findings out of 5):
- Waist circumference ≥ 90 cm (men) or ≥ 80 cm (women).
- Elevated triglyceride (TG) (use of lipid-lowering medication is an alternate indicator) ≥ 150 mg/dL (1.7 mmol/L).
- Reduced high-density lipoprotein cholesterol (HDL-c) (use of lipid-lowering medication is an alternate indicator) \< 40 mg/dL (1.0 mmol/L) in males \< 50 mg/dL (1.3 mmol/L) in females.
- Elevated blood pressure (use of antihypertensive medication is an alternate indicator). Systolic blood pressure (SBP) ≥ 130 and/or diastolic blood pressure (DBP) ≥ 85 mmHg.
- Elevated fasting blood glucose (FBG) (used of hypoglycemic medications is an alternate indicator) ≥ 100 mg/dL (5.6 mmol/L).
You may not qualify if:
- Unstable weight (change \> 10% current body weight) for 3 months prior to the study
- Pregnant or breast-feeding
- Night shift workers
- History of major diseases or related diseases, such as cancer, inflammatory disease, chronic obstructive pulmonary disease and major adverse cardiovascular event
- Active viral hepatitis, acquired immune deficiency syndrome, syphilis and other sexually transmitted diseases, tuberculosis and other infectious diseases
- Being treated with antibiotics or corticosteroids
- Current participate in other weight-management program, current on a prescribed diet for special disease or current on any drugs that effect appetite
- The researcher deemed it inappropriate to participate in the experimenter.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital of Xi 'an Jiaotong University
Xi'an, Shaanxi, 710061, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Bingyin Shi
First Affiliated Hospital Xi'an Jiaotong University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 13, 2023
First Posted
August 30, 2023
Study Start
May 7, 2024
Primary Completion
October 16, 2024
Study Completion
October 16, 2024
Last Updated
December 22, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual participant data (IPD) available to other researchers.